EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson’s Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites

Zofia Kinga Bytowska iD, Daria Korewo-Labelle iD, Paweł Berezka iD, Konrad Kowalski, Katarzyna Przewłócka iD, Witold Libionka, Wojciech Kloc iD, Jan Jacek Kaczor

International Journal of Molecular Sciences · 15.06.2023 · 24 (12) · 10200

DOI: 10.3390/ijms241210200 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.06.2023. Verfasst von Zofia Kinga Bytowska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bioenergetics and Physiology of Exercise, Faculty of Health Sciences with Institute of Maritime and Tropical Medicine, Medical University…. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases, Deep Brain Stimulation, Vitamin D Deficiency. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: POWR. co-financed by the European Union, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most common neurodegenerative disease. To manage motor symptoms not controlled adequately with medication, deep brain stimulation (DBS) is used. PD patients often manifest vitamin D deficiency, which may be connected with a higher risk of falls. We administered a 12-week vitamin D3 supplementation based on BMI (with higher doses given to patients with higher BMI) to investigate its effects on physical performance and inflammation status in PD patients with DBS. Patients were randomly divided into two groups: treated with vitamin D3 (VitD, n = 13), and supplemented with vegetable oil as the placebo group (PL, n = 16). Patients underwent functional tests to assess their physical performance three times during this study. The serum 25(OH)D3 concentration increased to the recommended level of 30 ng/mL in the VitD group, and a significant elevation in vitamin D metabolites in this group was found. We observed significant improvement in the Up and Go and the 6 MWT in the VitD group. In inflammation status, we noticed a trend toward a decrease in the VitD group. To conclude, achieving the optimal serum 25(OH)D3 concentration is associated with better functional test performance and consequently may have a positive impact on reducing falling risk in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesDeep Brain StimulationVitamin D DeficiencyHumansCholecalciferolBody Mass IndexVitamin DVitaminsDietary SupplementsInflammation

Stichwörter der Autor:innen

Parkinson’s diseasedeep brain stimulationfunctional testsinflammationvitamin D

Substanzen

CholecalciferolVitamin DVitamins

Autor:innen und Institutionen

  • Division of Bioenergetics and Physiology of Exercise, Faculty of Health Sciences with Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.
  • Department of Physiology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland.
  • Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, 80-309 Gdansk, Poland.
  • Masdiag-Diagnostic Mass Spectrometry Laboratory, Stefana Żeromskiego 33, 01-882 Warsaw, Poland.
  • Department of Neurosurgery, University Clinical Centre in Gdansk, 80-952 Gdansk, Poland.
  • Department of Neurosurgery, Copernicus Medical Center, 80-803 Gdansk, Poland.

ORCID-Profile: Zofia Kinga Bytowska, Daria Korewo-Labelle, Paweł Berezka, Katarzyna Przewłócka, Wojciech Kloc

Förderung

  • POWR. co-financed by the European Union
  • European Union

Zitieren

APA

Bytowska, Z. K., Korewo-Labelle, D., Berezka, P., Kowalski, K., Przewłócka, K., Libionka, W., Kloc, W., & Kaczor, J. J. (2023). Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson’s Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites. International Journal of Molecular Sciences, 24(12), 10200. https://doi.org/10.3390/ijms241210200

Vancouver

Bytowska ZK, Korewo-Labelle D, Berezka P, Kowalski K, Przewłócka K, Libionka W, et al. Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson’s Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites. International Journal of Molecular Sciences. 2023;24(12):10200. doi:10.3390/ijms241210200

BibTeX
@article{Bytowska2023,
  author = {Bytowska, Zofia Kinga and Korewo-Labelle, Daria and Berezka, Paweł and Kowalski, Konrad and Przewłócka, Katarzyna and Libionka, Witold and Kloc, Wojciech and Kaczor, Jan Jacek},
  title = {Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson’s Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {12},
  pages = {10200},
  doi = {10.3390/ijms241210200}
}
Kostenlos starten →